Vimarsana
Biggest News Aggregation in the World

Page 3 - Adaptive Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adaptive Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adaptive Research Today - Breaking & Trending Today

Global clinical trial provides new evidence on simvastatin and vitamin C for COVID-19 - Vimarsana News

Global clinical trial provides new evidence on simvastatin and vitamin C for COVID-19

The Global Coalition for Adaptive Research (GCAR) in collaboration with the University of Pittsburgh and UPMC, on behalf of the REMAP-CAP Investigator Network, announce clinical trial results examining the use of vitamin C and simvastatin to treat severely ill patients with COVID-19.

Statin linked to improved outcomes in COVID-19 patients, vitamin C shows no benefits - Vimarsana News

Statin linked to improved outcomes in COVID-19 patients, vitamin C shows no benefits

Clinical trials show vitamin C was not beneficial in critically ill COVID-19 patients, but the statin drug simvastatin had a 96% likelihood of improving outcomes.

Source: upi.com
Statin linked to improved outcomes in COVID-19 patients, vitamin C shows no benefits - Vimarsana News

Statin linked to improved outcomes in COVID-19 patients, vitamin C shows no benefits

Clinical trials show vitamin C was not beneficial in critically ill COVID-19 patients, but the statin drug simvastatin had a 96% likelihood of improving outcomes.

Source: yahoo.com
Children's Tumor Foundation and Global Coalition for Adaptive Research Announce Strategic Alliance to Implement NF Platform Clinical Trial - Vimarsana News

Children's Tumor Foundation and Global Coalition for Adaptive Research Announce Strategic Alliance to Implement NF Platform Clinical Trial

/PRNewswire/ -- The Children's Tumor Foundation (NEW YORK, NY and BRUSSELS, BELGIUM) and the Global Coalition for Adaptive Research (LARKSPUR, CA) – The...

Kintara Therapeutics Presents Case Studies of Glioblastoma Patients Treated with VAL-083 at 2023 European Association for Neuro-Oncology Annual Meeting - Vimarsana News

Kintara Therapeutics Presents Case Studies of Glioblastoma Patients Treated with VAL-083 at 2023 European Association for Neuro-Oncology Annual Meeting

SAN DIEGO, Sept. 25, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor therapies, today announced the presentation of...